TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01043601

Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Similar data obtained in another study \[see NCT01085045\], therefore study not implemented.”

The sponsor’s own words in the registry.

Life of this trial

201020112012201320142015Registered2010-01-05Planned start2010-07 (planned)Withdrawn (as of)2014-07-11

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Pearl Therapeutics, Inc.
Sponsor type
Industry
Conditions
COPD
Interventions
Inhaled PT005; Inhaled Placebo; Formoterol Fumarate 12 µg (Foradil Aerolizer)
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.